A detailed history of Hollencrest Capital Management transactions in Organon & Co. stock. As of the latest transaction made, Hollencrest Capital Management holds 426 shares of OGN stock, worth $6,274. This represents 0.0% of its overall portfolio holdings.

Number of Shares
426
Previous 425 0.24%
Holding current value
$6,274
Previous $8,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$18.65 - $23.03 $18 - $23
1 Added 0.24%
426 $8,000
Q1 2023

May 16, 2023

SELL
$21.42 - $32.08 $107 - $160
-5 Reduced 1.16%
425 $9,000
Q4 2022

Feb 06, 2023

BUY
$23.31 - $28.61 $10,023 - $12,302
430 New
430 $12,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.